Literature DB >> 1905770

Hyperglycemic properties of serotonin receptor antagonists.

K M Wozniak1, M Linnoila.   

Abstract

Several serotonin (5-HT) receptor antagonists with varying specificities for the 5-HT receptor types, were studied with regard to their effects on blood glucose levels in mice. The non-selective antagonists, metergoline and methysergide, proved to be hyperglycemic at doses commonly used to antagonize 5-HT receptors. In contrast, ritanserin (a 5-HT2 and 5-HT1c antagonist) and MDL 72222 (a 5-HT3 antagonist) were effective only at doses which surpassed the dose range considered to be selective for their respective receptors. The results suggest that 5-HT systems play a role in maintaining glucose homeostasis and that 5-HT1 receptors may be particularly important in this function. Furthermore, the inherent hyperglycemic properties of non-selective serotonin antagonists described here, are pertinent to studies using these agents to investigate glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905770     DOI: 10.1016/0024-3205(91)90023-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis.

Authors:  Eric D Berglund; Chen Liu; Jong-Woo Sohn; Tiemin Liu; Mi Hwa Kim; Charlotte E Lee; Claudia R Vianna; Kevin W Williams; Yong Xu; Joel K Elmquist
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

2.  Effect of buspirone: An anxiolytic drug on blood glucose in humans.

Authors:  S K Ojha; M Nandave; C Sharma
Journal:  Indian J Clin Biochem       Date:  2006-09

3.  Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.

Authors:  Ren-Rong Wu; Jing-Ping Zhao; Zhe-Ning Liu; Jin-Guo Zhai; Xiao-Feng Guo; Wen-Bing Guo; Jing-Song Tang
Journal:  Psychopharmacology (Berl)       Date:  2006-04-07       Impact factor: 4.530

4.  Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.

Authors:  Zhibo An; Mary C Moore; Jason J Winnick; Ben Farmer; Doss W Neal; Margaret Lautz; Marta Smith; Tiffany Rodewald; Alan D Cherrington
Journal:  Eur J Pharmacol       Date:  2009-04-01       Impact factor: 4.432

5.  Atypical Antipsychotics and Glucose Dysregulation: A Series of 4 Cases.

Authors:  Sanjay Gupta; Barbara Lentz; Kari Lockwood; Bradford Frank
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-04

Review 6.  Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Authors:  Kimberly A Stigler; Marc N Potenza; David J Posey; Christopher J McDougle
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia.

Authors:  X Fan; C P C Borba; P Copeland; D Hayden; O Freudenreich; D C Goff; D C Henderson
Journal:  Acta Psychiatr Scand       Date:  2012-09-04       Impact factor: 6.392

8.  5-hydroxytryptamine stimulates glucose transport in cardiomyocytes via a monoamine oxidase-dependent reaction.

Authors:  Y Fischer; J Thomas; J Kamp; E Jüngling; H Rose; H Kammermeier
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

9.  Regulation of blood pressure and glucose metabolism induced by L-tryptophan in stroke-prone spontaneously hypertensive rats.

Authors:  Hitoshi Shirakawa; Yuto Inagawa; Takuya Koseki; Michio Komai
Journal:  Nutr Metab (Lond)       Date:  2011-06-28       Impact factor: 4.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.